Compounded Semaglutide: The Complete Guide for 2026

Compounded semaglutide is not FDA-approved as a finished product. The active ingredient, semaglutide, is well-characterized and is semaglutide, which is also the active ingredient in certain FDA-approved branded medications. Compounded versions are prepared by licensed 503A compounding pharmacies under current Good Manufacturing Practice (cGMP) standards. Compounding is permitted under federal law to address drug shortages and patient access needs. Your FormBlends physician can discuss the regulatory nuances and help you make an informed decision.

Look for three things. First, verify that the pharmacy is a licensed 503A compounding pharmacy, you can check this on the FDA website. Second, confirm they follow cGMP standards and undergo state-board oversight and quality documentation. Third, ask for certificates of analysis (CoA) showing third-party potency and purity testing for each batch. Legitimate pharmacies like those used by FormBlends readily provide this documentation. Be wary of any provider that cannot or will not share their pharmacy credentials or testing results.

503A pharmacies are traditional compounding pharmacies that prepare medications based on individual prescriptions. They are regulated primarily by state boards of pharmacy and have less federal oversight. licensed 503A compounding pharmacies are federally regulated by the FDA, must follow cGMP standards, undergo state-board oversight and quality documentation, and can produce larger quantities for distribution. FormBlends sources through licensed 503A pharmacies because they provide the highest level of regulatory oversight, quality control, and batch testing available in the compounding space.

Compounded semaglutide should be refrigerated at 36-46 degrees Fahrenheit (2-8 degrees Celsius) before first use. Once in use, it can typically be stored at room temperature (up to 77 degrees Fahrenheit / 25 degrees Celsius) for up to 28 days, depending on the specific formulation. Never freeze semaglutide. Protect from direct sunlight and heat. Your FormBlends medication ships with appropriate cold-chain packaging, and specific storage instructions are included with every shipment.

A standard semaglutide titration starts at 0.25mg weekly for 4 weeks, then increases to 0.5mg weekly for 4 weeks, then to 1.0mg weekly. Some patients titrate further to 1.7mg or 2.4mg based on response and tolerance. The purpose of gradual titration is to minimize gastrointestinal side effects, nausea, diarrhea, and reduced appetite are most common during dose increases. Your FormBlends physician personalizes your titration schedule based on your individual response, adjusting the pace up or down as needed.

Semaglutide is injected subcutaneously (into the fat layer beneath the skin) once weekly. Recommended injection sites are the abdomen (at least 2 inches from the navel), front of thighs, or upper arms. Rotate injection sites weekly to prevent tissue irritation. Clean the injection site with an alcohol swab, pinch the skin, insert the needle at a 45-90 degree angle, inject slowly, and hold for 5-10 seconds before withdrawing. Your FormBlends care team provides detailed injection training during onboarding.

A trustworthy compounded GLP-1 provider should offer: board-certified physician oversight (not nurse practitioners prescribing independently), transparent sourcing from named 503B facilities, certificates of analysis available on request, individualized dosing protocols (not one-size-fits-all), ongoing physician monitoring with real dose adjustments, clear pricing with no hidden fees, and HIPAA-compliant telehealth infrastructure. If a provider cannot tell you which pharmacy compounds their medication or will not share testing documentation, that is a significant red flag.